Macula Densa Cells are specialized epithelial cells located in the distal tubule of the nephron within the kidney. These cells play a pivotal role in the regulation of renal function and blood pressure. Macula densa cells are crucial components of the juxtaglomerular apparatus, which also includes granular cells and extraglomerular mesangial cells. Macula densa cells sense changes in sodium chloride concentration in the filtrate passing through the distal tubule. This information is conveyed to the adjacent granular cells, triggering the release of renin. Renin, in turn, initiates the renin-angiotensin-aldosterone system, leading to increased blood pressure and sodium reabsorption. The intricate communication between macula densa cells and the juxtaglomerular apparatus is essential for maintaining renal perfusion and electrolyte balance. Dysregulation of macula densa function can contribute to conditions like hypertension or renal dysfunction. Studying the physiology of macula densa cells provides valuable insights into renal homeostasis, blood pressure regulation, and the pathophysiology of various kidney disorders. Ongoing research aims to elucidate the molecular mechanisms underlying macula densa cell function, paving the way for potential therapeutic interventions targeting renal and cardiovascular health.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy